NET PROFIT (x1000 DKK)
EMPLOYEES
Glucox Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-1,141
|
-947
|
-903 |
EBITDA |
-488
|
-462
|
-537 |
Total assets |
4,564
|
1,995
|
2,103 |
Current assets |
267
|
144
|
552 |
Current liabilities |
167
|
179
|
42 |
Equity capital |
-1,163
|
-22
|
1,006 |
- share capital |
1,043
|
1,038
|
1,129 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-25.5%
|
-1.1%
|
47.8% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-25.0%
|
-47.5%
|
-42.9% |
Current ratio |
159.9%
|
80.4%
|
1314.3% |
Return on equity (ROE) |
98.1%
|
4304.5%
|
-89.8% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.